BioV Global
BIOV Global is transforming the future of aging with state-of-the-art regenerative therapies and integrative health solutions designed to enhance health-span, vitality, and well-being.
Visit Website
BioV Global At a Glance
BioV Global is a world-leading provider of regenerative medicine and integrative health solutions, redefining the aging journey for a healthier, more energetic population. Their unique approach merges cutting-edge regenerative therapies with a holistic health model, addressing the complex challenges of aging by enhancing health-span and overall well-being.
About us
Why ISTAR Invested
Strategic Investment in Regenerative Healthcare
ISTAR invested in BioV Global due to its innovative approach to regenerative medicine, strong clinical credibility, and globally scalable model.
Key Services & Products
Explore how our innovative services and products have empowered businesses to scale faster and more effectively, driving success across industries.
O1
BioV Cellular Program
Delivers one of the most advanced regenerative therapies by combining Mesenchymal Stem Cells (MSCs) from Wharton’s Jelly with pure MSC exosomes, this dual-action treatment targets the root of aging and chronic conditions.
O2
BioV Ecosystem
BioV Global isn’t just a medical breakthrough, it’s a regenerative health ecosystem. Through our Consumer Shareholding Model, clients and healthcare professionals can become our stakeholders toward IPO.
About us
How we evolved from an idea to a thriving company
Our journey began with a bold vision and a clear mission — to create lasting impact through innovation. Along the way, we've grown through challenges, celebrated milestones, and built meaningful partnerships. This path reflects our commitment to learning, evolving, and delivering value every step of the way.
2004 - 2009
Founded to lead in regenerative health and anti-aging therapy.
2010 - 2014
Listed on KLSE, building credibility in stem cell therapy.
2015 - 2020
Secured cGMP, ISO, and built a certified stem cell lab.
2021 - 2023
Entered 8 countries and launched consumer-shareholder model.
2024 - 2027
Introduced MSC program and preparing for global IPO.
Future Look
Growth and Innovation Plan
BioV Global aims to become a global leader in stem cell and regenerative healthcare. With certified labs, top-tier scientists, and expansion into 12 countries, it’s poised to transform the future of aging and chronic disease treatment.
Global Leadership in Regenerative Medicine
Disruptive Consumer-Shareholder Business Model
Through an innovative model, BioV Global turns patients into shareholders—converting treatment costs into equity. This creates both access to cutting-edge care and long-term financial value for every participant.
The company is on track for IPO, supported by recruitment of doctors, clinic partners, and global referral networks. Its scalable system is designed to replicate Malaysia’s success across Asia and beyond.
Strategic Roadmap to IPO & Scalable Growth
Discover how the company plans to drive growth, foster innovation, and create lasting impact for the future.
About us
BioV Global At a Glance
BioV Global is a world-leading provider of regenerative medicine and integrative health solutions, redefining the aging journey for a healthier, more energetic population. Their unique approach merges cutting-edge regenerative therapies with a holistic health model, addressing the complex challenges of aging by enhancing health-span and overall well-being.
Why ISTAR Invested
Strategic Investment in Regenerative Healthcare
ISTAR invested in BioV Global due to its innovative approach to regenerative medicine, strong clinical credibility, and globally scalable model.
Key Services & Products
Explore how our innovative services and products have empowered businesses to scale faster and more effectively, driving success across industries.
O1
BioV Cellular Program
Delivers one of the most advanced regenerative therapies by combining Mesenchymal Stem Cells (MSCs) from Wharton’s Jelly with pure MSC exosomes, this dual-action treatment targets the root of aging and chronic conditions.
O2
BioV Ecosystem
BioV Global isn’t just a medical breakthrough, it’s a regenerative health ecosystem. Through our Consumer Shareholding Model, clients and healthcare professionals can become our stakeholders toward IPO.
About us
How we evolved from an idea to a thriving company
Our journey began with a bold vision and a clear mission — to build an inclusive digital society connecting talent, technology, and opportunities. From a small initiative, we have grown into a thriving regional hub, overcoming challenges, celebrating milestones, and forging partnerships that strengthen our foundation for innovation and sustainable growth
2004 - 2009
Founded to lead in regenerative health and anti-aging therapy.
2010 - 2014
Listed on KLSE, building credibility in stem cell therapy.
2015 - 2020
Secured cGMP, ISO, and built a certified stem cell lab.
2021 - 2023
Entered 8 countries and launched consumer-shareholder model.
2024 - 2027
Introduced MSC program and preparing for global IPO.
Future Outlook
Growth and Innovation Plan
Discover how the company plans to drive growth, foster innovation, and create lasting impact for the future.
BioV Global aims to become a global leader in stem cell and regenerative healthcare. With certified labs, top-tier scientists, and expansion into 12 countries, it’s poised to transform the future of aging and chronic disease treatment.
Global Leadership in Regenerative Medicine
Disruptive Consumer-Shareholder Business Model
Through an innovative model, BioV Global turns patients into shareholders—converting treatment costs into equity. This creates both access to cutting-edge care and long-term financial value for every participant.
The company is on track for IPO, supported by recruitment of doctors, clinic partners, and global referral networks. Its scalable system is designed to replicate Malaysia’s success across Asia and beyond.
Strategic Roadmap to IPO & Scalable Growth
